Compare Sangal Papers with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.69%
- Poor long term growth as Net Sales has grown by an annual rate of 13.00% and Operating profit at 7.83% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.33 times
Flat results in Dec 25
38.76% of Promoter Shares are Pledged
Underperformed the market in the last 1 year
Stock DNA
Paper, Forest & Jute Products
INR 26 Cr (Micro Cap)
15.00
18
0.00%
0.57
3.74%
0.51
Total Returns (Price + Dividend) 
Sangal Papers for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Are Sangal Papers Ltd latest results good or bad?
Sangal Papers Ltd's latest financial results for Q2 FY26 indicate significant operational challenges. The company reported net sales of ₹48.35 crores, reflecting a year-on-year decline of 5.55% compared to ₹51.19 crores in Q2 FY25, despite a slight sequential increase of 1.64% from the previous quarter. This revenue contraction is coupled with a substantial drop in net profit, which fell to ₹0.30 crores, an 81% decrease year-on-year, highlighting severe profitability pressures. The operating margin, which stood at 2.38%, represents a considerable decline of 413 basis points from the previous year's margin of 6.51%. This low margin suggests that the company is facing significant pricing pressures or rising input costs. Furthermore, the return on equity (ROE) has been reported at 6.00%, which is considered below average, indicating that the company is generating insufficient returns relative to the capital i...
Read full news article
Sangal Papers Ltd is Rated Strong Sell
Sangal Papers Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Sangal Papers Ltd Valuation Shifts Signal Renewed Price Attractiveness
Sangal Papers Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, driven primarily by its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios. Despite this improvement in valuation metrics, the company’s overall financial health and market performance present a mixed picture, prompting a cautious stance from analysts and investors alike.
Read full news article Announcements 
Intimation For Opening Of Special Window For Lodgement/Relodgement Of Tranfer Request By Shareholders.
12-Feb-2026 | Source : BSEIntimation for Opening of special window for lodgement/relodgement of tranfer request by shareholders.
Board Meeting Intimation for Intimation Of Board Meeting For Approval Of Unaudited Results For The Quarter Ended On 31.12.2025.
31-Jan-2026 | Source : BSESangal Papers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Intimation of board meeting for approval of un-audited results for the quarter ended on 31.12.2025
Announcement Under Regulation 30 Of SEBI(LODR) Regulations 2015.
30-Jan-2026 | Source : BSEAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
38.7565
Held by 0 Schemes
Held by 0 FIIs
Amit Sangal (9.26%)
Mahendra Girdharilal (2.72%)
58.5%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -3.41% vs 1.64% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 16.67% vs -62.50% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 2.27% vs -2.40% in Sep 2024
Growth in half year ended Sep 2025 is -50.22% vs 384.78% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 6.87% vs -5.80% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -39.17% vs 49.07% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -5.29% vs -15.82% in Mar 2024
YoY Growth in year ended Mar 2025 is 14.57% vs -27.14% in Mar 2024






